secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001493152-26-012701
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tevogen Bio regains Nasdaq minimum bid price compliance after reverse split
---------------------------------------------------------------------------

- Received Nasdaq notice on March 20, 2026 confirming compliance with Listing Rule 5450(a)(1).
- Compliance achieved via 1-for-50 reverse stock split of common stock effective March 6, 2026.
- Nasdaq matter now closed; no further delisting risk from this requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226012701/0001493152-26-012701-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315226012701/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-012701

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer